Facultad de Ciencias de la Salud
Faculté
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (46)
2023
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Automatic antibiotic resistance prediction in Klebsiella pneumoniae based on MALDI-TOF mass spectra
Engineering Applications of Artificial Intelligence, Vol. 118
-
Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α
International journal of molecular sciences, Vol. 24, Núm. 7
2022
-
The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives
Microorganisms, Vol. 10, Núm. 4
2021
-
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown
Scientific Reports, Vol. 11, Núm. 1
2020
-
Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella
Medical Mycology, Vol. 58, Núm. 1, pp. 83-92
-
Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))
Clinical Microbiology and Infection
-
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial
Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162
2019
-
Does the composition of polystyrene trays affect candida spp. biofilm formation?
Medical Mycology, Vol. 57, Núm. 4, pp. 504-509
-
Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614
-
Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis
Journal of Cystic Fibrosis, Vol. 18, Núm. 5, pp. 630-635
2018
-
Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years
Journal of Antimicrobial Chemotherapy
-
Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect
Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4
-
Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata
Medical Mycology, Vol. 56, Núm. 7, pp. 903-906
-
Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1200-1204
-
Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates
Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3
-
Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples
Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6
2017
-
Antibiotic prescription patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 391-400